source
- FDA issues warning letters to drug manufacturers in India, China and US over GMP violationsThe FDA has sent formal warning letters to several companies located in India, China and the United States. The letters cite multiple breaches of current good manufacturing practice standards in t…
- Biotech IPOs approach ‘escape velocity’ barring yellow flags that could threaten reboundTwenty-five biotechs have used the IPO route to go public this year—with five of those debuts occurring this month alone. It’s the most IPOs since 2021, when the industry recorded 78 during the hei…